Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 10132-10141

  Chen, X P ^a   Li, J ^a   Mata, M ^a   Goss, J ^a   Wolfe, D ^a   Glorioso, J C ^a   Fink, D J ^a  

^a S 520 BST ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; PHOSPHOPROTEIN PHOSPHATASE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; RAT; TRANSACTIVATION; TRIGEMINUS GANGLION; VIROGENESIS; VIRUS GENE; VIRUS INFECTION;

ANIMAL; CALCINEURIN; CALPAIN; CELL NUCLEUS; CELLS, CULTURED; HERPESVIRUS 1, HUMAN; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEURONS; PC12 CELLS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS LATENCY;

EID: 0033779586     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.10132-10141.2000     Document Type: Article

References (65)

1. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
2. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase
3. An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products
4. Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function
5. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation
6. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells
7. Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA
8. Alternatively spliced mRNAs predicted to yield frame-shift proteins and stable intron 1 RNAs of the herpes simplex virus 1 regulatory gene alpha 0 accumulate in the cytoplasm of infected cells
9. A novel nuclear substructure, ND10: Distribution in normal and neoplastic human tissues
10. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate
11. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
12. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
13. Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110
14. Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1
15. A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1
16. Transaetivation of transcription by herpes virus products: Requirement for two HSV-1 immediate-early polypeptides for maximum activity
17. A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner
18. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
19. HSV-1 IE protein Vmw110 causes redistribution of PML
20. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication
21. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
22. Gene transfer to neurons using herpes simplex virus-based vectors
23. Phosphorylation modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins
24. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
25. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
26. Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro
27. Interaction of herpes simplex virus 1 α regulatory protein ICP0 with elongation factor 1δ: ICP0 affects translational machinery
28. Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cells
29. Regulated transcription of herpes simplex virus immediate-early genes in neuroblastoma cells
30. Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus
31. A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins
32. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications
33. Host cell protein binds to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 α genes
34. DNA-binding site of major regulatory protein α4 specifically associated with the promoter-regulatory domains of a genes of herpes simplex virus type I
35. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency
36. Activation of the herpes simplex virus immediate-early gene promoters by neuronally expressed POU family transcription factors
37. Detection of herpes simplex virus type 1 gene expression in latently and productively infected mouse ganglia using the polymerase chain reaction
38. Nuclear domain 10, the site of DNA virus transcription and replication
39. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0)
40. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1
41. Regulation of herpes simplex virus 1 genes: Alpha gene sequence requirements for transient induction of indicator genes regulated by beta or late (gamma 2) promoters
42. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient
43. Casein kinase II specifically nucleotidylylates in vitro the amino acid sequence of the protein encoded by the alpha 22 gene of herpes simplex virus 1
44. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
45. Herpes simplex virus gene expression in neurons: Viral DNA synthesis is a critical regulatory, event in the branch point between the lyric and latent pathways
46. Infection of sympathetic and sensory neurons with herpes simplex virus does not elicit a shut-off of cellular protein synthesis: Implications for viral latency and herpes vectors
47. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0
48. Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate-early gene expression
49. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters
50. Examination of determinants for intranuclear localization and transactivation within the RING finger of herpes simplex virus type 1 IE110k protein
51. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions
52. Herpes simplex viruses and their replication
53. Herpes simplex viruses and their replication
54. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture
55. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
56. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon
57. Establishment of herpes simplex virus latency in vitro with cycloheximide
58. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110
59. Attachment of herpes simplex virus to neurons and glial cells
60. Herpes simplex genes: The blueprint of a successful buman pathogen
61. Antiviral properties of a dominant negative mutant of the herpes simplex virus type 1 regulatory protein ICP0
62. Identification of dominant-negative mutants of the herpes simplex virus type 1 immediate-early protein ICP0
63. Establishment of latency in vitro with herpes simplex virus temperature-sensitive mutants at nonpermissive temperature
64. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0
65. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27